Uncovering resistance pathways to first- and last-line antibiotics in Mycobacterium tuberculosis populations
Prapaporn Srilohasin, Jasmine M. Williams, Aidan P. Tay, Brodie F. Gillieatt, Daniel R. Pascoe, Ram P. Maharjan, Angkana Chaipraset, Pravech Ajawatanawong, Amy K. Cain · 2026
Read Uncovering resistance pathways to first- and last-line antibiotics in Mycobacterium tuberculosis populations by Prapaporn Srilohasin, Jasmine M. Williams, Aidan P. Tay, Brodie F. Gillieatt, Daniel R. Pascoe, Ram P. Maharjan, Angkana Chaipraset, Pravech Ajawatanawong, Amy K. Cain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13186403.txt.
Description
Prapaporn Srilohasin and eight co-authors trace the paths tuberculosis bacteria take to resist first-line and last-line drugs. Their study was published in twenty twenty-six. TB kills about one and a half million people a year, and drug-resistant TB was lately named a critical priority threat.
Few lab studies have mapped in a controlled way how resistance grows step by step. The team evolved TB populations in the lab under drug pressure and read their genes deeply over time. Most populations picked up changes in the very genes found in resistant patients: one for rifampicin resistance, another for linezolid. Some paths, though, differed from the usual clinical picture. The map can help labs predict resistance and design drug use that slows it.
Catalog record
| CREATOR | Prapaporn Srilohasin, Jasmine M. Williams, Aidan P. Tay, Brodie F. Gillieatt, Daniel R. Pascoe, Ram P. Maharjan, Angkana Chaipraset, Pravech Ajawatanawong, Amy K. Cain |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |